Keshavarz K - Search Results

1

Cost-Effectiveness Analysis of Biopharmaceuticals for Treating Rheumatoid Arthritis: Infliximab, Adalimumab, and Etanercept.

Gholami A, Azizpoor J, Aflaki E, Rezaee M, Keshavarz K. Gholami A, et al. Among authors: keshavarz k. Biomed Res Int. 2021 Nov 28;2021:4450162. doi: 10.1155/2021/4450162. eCollection 2021. Biomed Res Int. 2021. PMID: 34877355 Free PMC article.

2

Relationship of arginine and methionine to creatine formation in chicks.

Keshavarz K, Fuller HL. Keshavarz K, et al. J Nutr. 1971 Jul;101(7):855-62. doi: 10.1093/jn/101.7.855. J Nutr. 1971. PMID: 5104734 No abstract available.

3

The influence of widely fluctuating temperatures on heat production and energetic efficiency of broilers.

Keshavarz K, Fuller HL. Keshavarz K, et al. Poult Sci. 1980 Sep;59(9):2121-8. doi: 10.3382/ps.0592121. Poult Sci. 1980. PMID: 7433370 Free article.

4

Relationship of arginine and methionine in the nutrition of the chick and the significance of creatine biosynthesis in their interaction.

Keshavarz K, Fuller HL. Keshavarz K, et al. J Nutr. 1971 Feb;101(2):217-22. doi: 10.1093/jn/101.2.217. J Nutr. 1971. PMID: 5540442 No abstract available.

5

Cost-effectiveness of rabies post exposure prophylaxis in Iran.

Hatam N, Esmaelzade F, Mirahmadizadeh A, Keshavarz K, Rajabi A, Afsar Kazerooni P, Ataollahi M. Hatam N, et al. Among authors: keshavarz k. J Res Health Sci. 2014 Spring;14(2):122-7. J Res Health Sci. 2014. PMID: 24728746 Free article.

6

Blood transfusion versus hydroxyurea in beta-thalassemia in Iran: a cost-effectiveness study.

Ravangard R, Mirzaei Z, Keshavarz K, Haghpanah S, Karimi M. Ravangard R, et al. Among authors: keshavarz k. Hematology. 2018 Aug;23(7):417-422. doi: 10.1080/10245332.2017.1404262. Epub 2017 Nov 21. Hematology. 2018. PMID: 29157136

7

Estimating the Cost of Illness of Prostate Cancer in Iran.

Mojahedian MM, Toroski M, Keshavarz K, Aghili M, Zeyghami S, Nikfar S. Mojahedian MM, et al. Among authors: keshavarz k. Clin Ther. 2019 Jan;41(1):50-58. doi: 10.1016/j.clinthera.2018.11.001. Epub 2018 Dec 10. Clin Ther. 2019. PMID: 30545740

8

Fingolimod versus natalizumab in patients with relapsing remitting multiple sclerosis: a cost-effectiveness and cost-utility study in Iran.

Rezaee M, Izadi S, Keshavarz K, Borhanihaghighi A, Ravangard R. Rezaee M, et al. Among authors: keshavarz k. J Med Econ. 2019 Apr;22(4):297-305. doi: 10.1080/13696998.2018.1560750. Epub 2019 Jan 8. J Med Econ. 2019. PMID: 30561242 Free article.

9

Economic burden of hemophilia A and B: a case in Iran.

Keshavarz K, Bordbar M, Hashemipoor Z, Jalali FS, Ravangard R. Keshavarz K, et al. Hematology. 2020 Dec;25(1):149-155. doi: 10.1080/16078454.2020.1741205. Hematology. 2020. PMID: 32249720

10

Cost-utility analysis of factor VIII diet therapies prepared using blood plasma vs. recombinant technique for patients with hemophilia A.

Lotfi F, Talebianpour H, Keshavarz K, Emadi F, Bordbar MR, Bastani P. Lotfi F, et al. Among authors: keshavarz k. Daru. 2020 Jun;28(1):287-293. doi: 10.1007/s40199-020-00347-8. Epub 2020 Apr 22. Daru. 2020. PMID: 32323144 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page